Use of belimumab throughout pregnancy to treat active systemic lupus erythematosus—A case report
Danve A, Perry L, Deodhar A. Use of belimumab throughout pregnancy to treat active systemic lupus erythematosus—A case report. Seminars In Arthritis And Rheumatism 2014, 44: 195-197. PMID: 25005336, DOI: 10.1016/j.semarthrit.2014.05.006.Peer-Reviewed Original ResearchConceptsActive systemic lupus erythematosusSystemic lupus erythematosusUse of belimumabCase reportLupus erythematosusPresence of SLEMild Ebstein's anomalyFirst case reportBelimumab usePregnancy RegistryActive lupusUnacceptable toxicityEbstein's anomalyUneventful coursePoor outcomeCaucasian womenBelimumabPregnancyModerate dosesMycophenolateErythematosusReportRelevant literatureAzathioprinePrednisoneAmyloid Beta-Related Angiitis—A Case Report and Comprehensive Review of Literature of 94 Cases
Danve A, Grafe M, Deodhar A. Amyloid Beta-Related Angiitis—A Case Report and Comprehensive Review of Literature of 94 Cases. Seminars In Arthritis And Rheumatism 2014, 44: 86-92. PMID: 24636849, DOI: 10.1016/j.semarthrit.2014.02.001.Peer-Reviewed Original ResearchConceptsCerebral amyloid angiopathyPrimary central nervous system vasculitisE4/E4 genotypeCentral nervous system vasculitisClinical featuresAmyloid angiopathyMRI findingsBrain biopsyCase reportE4 genotypeAmyloid betaSusceptibility-weighted imagesCortico-subcortical junctionPresence of microbleedsFocal neurological deficitsFluid attenuation inversion recovery (FLAIR) imagesPrimary CNS vasculitisCharacteristic MRI findingsInversion recovery imagesCNS vasculitisReview of literatureAdditional immunosuppressantsGranulomatous vasculitisImmunosuppressant therapyNeurological deficits